NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

An inhibitor of lipid signaling suppresses HIV expression.

Leung D, Peterson P, Gekker G, Chao C, Bursten S, Bianco J, Singer J; International Conference on AIDS.

Int Conf AIDS. 1994 Aug 7-12; 10: 33 (abstract no. 423A).

Cell Therapeutics, Inc., Seattle, WA 98119.

OBJECTIVE: To test whether an inhibitor of phosphatidic acid (PA) generation, CT-2576, would suppress the expression and replication of HIV in cells. METHODS: A reporter gene expression system under the control of the HIV-LTR promotor in 293-EBNA cells was set up as a surrogate marker to screen compounds that inhibit HIV-LTR directed expression through blocking of PA. The selected compounds were then tested for their capability of inhibiting HIV expression in the chronically HIV infected promonocyte U1 cell line. RESULTS: CT-2576 inhibited the activation of HIV-LTR promotor by tat or TNF-a with an IC50 value of about 5 microM with minimal cytotoxicity on 293-EBNA cells. CT-2576 was also effective in inhibiting CMV and SV40 early promotor activity but had little effect on the housekeeping gene, phosphoglycerate kinase, promotor activity. CT-2576 suppressed the constitutive expression as well as the TNF-a or IL-6 mediated induction of HIV-1 p24 antigen in U1 cells with an IC50 value of around 1 microM. DISCUSSIONS AND CONCLUSIONS: CT-2576 inhibited the cytokine-induced and tat-directed expression of HIV with minimal cytotoxicity. CT-2576 inhibited HIV expression by interfering with the intracellular signaling phospholipid PA which appears critical to cell activation. CT-2576 and other compounds that can suppress PA generation should be of therapeutic interest for delaying or preventing the onset of AIDS and certain other viral diseases in HIV-infected patients.

Publication Types:
  • Meeting Abstracts
Keywords:
  • AIDS Vaccines
  • Acquired Immunodeficiency Syndrome
  • Anti-HIV Agents
  • CT 2576
  • Cell Line
  • Cytokines
  • Gene Expression
  • Gene Expression Regulation, Viral
  • Gene Products, tat
  • Genes, Reporter
  • Genes, tat
  • HIV
  • HIV Infections
  • HIV Long Terminal Repeat
  • HIV Seropositivity
  • Humans
  • Interleukin-6
  • Lipids
  • Monocytes
  • Signal Transduction
  • Xanthines
  • antagonists & inhibitors
  • genetics
Other ID:
  • 94372000
UI: 102210833

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov